Home: Info: News Releases: 2003 Archives
  Press Releases 2003 Archives

December 23, 2003
Study Demonstrating Efficacy of ON-Q Post-Surgical Pain Relief Treatment Following Foot and Ankle Surgery Published in Prestigious Anesthesiology Journal

December 8, 2003
I-Flow Will Present at the First Albany Growth Conference on Wednesday, December 10, 2003 at 1:40 PM ET

December 2, 2003
Published Study Demonstrates Benefits of ON-Q Post-Surgical Pain Relief Treatment Following Breast Cancer Surgery

November 24, 2003
Journal of Thoracic and Cardiovascular Surgery Publishes Study of ON-Q Post-Surgical Pain Relief Alternative Following Open Heart Surgery

October 29, 2003
I-Flow's Third Quarter Total Revenue Climbs 35% to Record $13 Million, Regional Anesthesia Sales Gain 66%

October 28, 2003
I-Flow Agrees to Sell Spinal Specialties Subsidiary To Integra LifeSciences For Approximately $6 Million

October 24, 2003
I-Flow Corporation To Release Third Quarter Results On Wednesday, October 29, 2003; WebCast Set For 11:00 a.m. ET

October 23, 2003
Benefits of ON-Q Post-Operative Pain Relief System Presented at American College of Surgeons 89th Annual Clinical Congress

October 17, 2003
I-Flow Honored With Seventh Deloitte & Touche Orange County Technology Fast 50 Ranking of Fastest Growing Technology Companies; I-Flow Is Award's Only Seven-Time Winner

October 15, 2003
Study Showing Efficacy Of ON-Q Post-Operative Pain Relief Treatment Following Open-Heart Surgery Published in Prestigious Anesthesiology Journal

September 25, 2003
Benefits of ON-Q Post-Surgical Pain Relief System Presented at the 21st World Congress on Endourology

September 17, 2003
I-Flow Corporation and Steiner Sports Enter Agreement To Promote ON-Q Post-Surgical Pain Relief System

September 16, 2003
I-Flow Will Present at the ThinkEquity Partners Growth Conference on Wednesday, September 17 at 7:45 AM PDT

September 5, 2003
I-Flow Will Present at The Roth Capital Partners New York Conference on Wednesday, September 10 at 8:30 AM EDT

September 3, 2003
I-Flow Announces $12.5 Million Private Placement of Common Stock and Warrants

September 2, 2003
I-Flow Announces Start of Study of ON-Q Pain Relief Device Following Breast Reconstruction Surgery at M. D. Anderson Cancer Center

July 29, 2003
I-Flow's Second Quarter Regional Anesthesia Sales Surge 58%; Total Revenue Climbs 32% to a Record $12.6 Million

July 24, 2003
I-Flow Corporation To Release Second Quarter Results On Tuesday, July 29, 2003; WebCast Set For 11:00 a.m. ET

July 22, 2003
I-Flow Corporation to Begin Trading on the NASDAQ National Market System on July 23, 2003

July 8, 2003
Presentation at Meeting of American Society of Colon and Rectal Surgeons Cites Benefits Of ON-Q Post-Operative Pain Relief System

June 11, 2003
Washington University Begins Study of Wound Healing with ON-Q® Post-Operative Pain Relief System

April 29, 2003
I-Flow's First Quarter Regional Anesthesia Sales Jump 69%, Pushing Total Revenue Up 31% To A Record $11.2 Million

March 17, 2003
I-Flow to Expand Sales Force To Capitalize on Growing Demand for its Flagship ON-Q Brand

March 10, 2003
Yale Researchers Begin Study of Promising New Pain Relief Device Following Cesarean Section

February 27, 2003
I-Flow Posts Record Fourth Quarter and 2002 Revenue

February 3, 2003
Presentation at Society of Gynecologic Oncologists Annual Meeting Discusses Post-Surgical Pain Relief Following Mastectomy

January 21, 2003
I-Flow Launches ON-Q® Elite Pain Relief System

January 2, 2003
"Analyst Research", Taglich Brothers, Inc. initiates research coverage on I-Flow Corporation. Taglich Brothers, Inc. is a full service brokerage firm specializing in the Microcap segment of the financial markets.

JOBS | NEWS | SITEMAP | SALES INFOCENTER
HEALTHCARE COMPLIANCE PROGRAM | HIPAA PRIVACY NOTICE

© 2004-2010 I-FLOW CORPORATION. All Rights Reserved

There are inherent risks in all medical devices, please refer to the product labeling for Indications, Cautions, Warnings and Contraindications.For example, failure to follow the product labeling regarding filling, flow rate selection and placement of the pump and/or catheter could directly impact patient safety. Physician is responsible for prescribing and administering medications per instructions provided by the drug manufacturer.